Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
06/13/2002 | US20020071808 Method for imaging malignant tumors using carbon 13 with MRI |
06/13/2002 | US20020071807 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
06/13/2002 | CA2436601A1 Perturbed membrane-binding compounds |
06/12/2002 | EP1212103A1 4-fluoroalkyl-3-halophenyl nortropanes |
06/12/2002 | EP0888354B1 Process for producing radiolabelled benzodiazepine receptor agents and composition containing the same |
06/11/2002 | US6403771 Loading onto binding medium relatively long lived radioisotope, decay sequence yielding daughter isotopes that emit predominantly alpha-and/or beta-particles, eluting alpha-particle emitting isotope, coupling to targeting moiety |
06/11/2002 | US6403096 Dimer, linked by a disulfide bridge; improves the uptake of therapeutic and diagnostic agents at a tumor site |
06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
06/11/2002 | US6403054 Ternary ligand complexes useful as radiopharmaceuticals |
06/06/2002 | WO2002044217A2 Humanised antibodies and uses thereof |
06/06/2002 | WO2002044175A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
06/06/2002 | WO2002044144A2 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds |
06/06/2002 | WO2002043776A2 Neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer |
06/06/2002 | WO2002043570A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES |
06/06/2002 | WO2001066155A3 Actinium-225 complexes and conjugates for radioimmunotherapy |
06/06/2002 | US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer |
06/06/2002 | US20020068328 Liposomal pharmaceutical conjugate for use inthe treatment and diagnosis of tumors; antitumor agents; anticarcinogeneic agents |
06/06/2002 | US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
06/06/2002 | US20020068037 Cascade polymer bound complexing compounds, their complexes and conjugates, process for their production, and pharmaceutical agents containing them |
06/06/2002 | DE10040381C1 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with sugar residues, processes for their preparation and their use |
06/06/2002 | CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies |
06/06/2002 | CA2429632A1 Neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer |
06/05/2002 | EP1210353A1 Calcium complex of phosphorus containing ethylenediamine derivatives |
06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
06/05/2002 | EP1210127A1 Radiopharmaceutical products and their preparation procedure |
06/05/2002 | EP1210125A2 L-selectin contrast agents |
06/05/2002 | EP1210082A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
06/05/2002 | EP1210068A2 Use of simple amino acids to form porous particles |
06/05/2002 | EP0815134B1 Modulators of amyloid aggregation |
06/04/2002 | US6399635 N,n-diethyl-4-(n-piperidin-3-yl-anilino) benzamide compound; reductive amination of a 3-piperidone, arylation |
06/04/2002 | US6399068 Cancer treatment, interleukins, fusion proteins, cell markers |
06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
06/04/2002 | US6399043 Radiolabeled macrocyclic gadolinium complexes with substantially better neural compatibility; enhanced signal intensity for nuclear spin tomography; water solubility and low osmolality; stable; nmr; radioimaging |
06/04/2002 | US6399042 4-fluoroalkyl-3-halophenyl nortropanes |
05/30/2002 | WO2002041989A1 Metal-chelating adsorbents and their use |
05/30/2002 | WO2002041923A1 Preparation for curing oncological disease, method for producing and using said composition |
05/30/2002 | WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
05/30/2002 | WO2001083520A3 Polyacid glycopeptide derivatives |
05/30/2002 | WO2001068679A3 Peptides targeting specifically tumor-derived endothelial cells |
05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
05/30/2002 | US20020065429 Radioiodinated phospholipid ether analogs and methods of using the same |
05/30/2002 | US20020065326 Patient oxygenation using stabilized fluorocarbon emulsions |
05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
05/30/2002 | US20020064554 Radiation sensitive liposomes |
05/30/2002 | US20020064500 Administering detectable amount of a radiolabeled compound of a class of benzisoxazoles; imaging brain to generate a brain image showing a distribution and relative amounts of acetylcholinesterase in brain |
05/29/2002 | EP1208852A1 Neuropeptide Y1 receptor binding compounds in the treatment and diagnosis of cancer |
05/29/2002 | EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
05/29/2002 | EP1208116A2 Somatostatin analogs, radiolabelled derivatives thereof and their use |
05/29/2002 | EP1207911A2 Improved container composition for radiopharmaceutical agents |
05/29/2002 | EP1207910A2 Improved container composition for diagnostic agents |
05/29/2002 | EP1207906A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies |
05/29/2002 | EP1207904A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
05/28/2002 | US6395783 Treatment of PCP addiction and PCP addiction-related behavior |
05/28/2002 | US6395255 Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy |
05/28/2002 | US6395254 Diagnosis of tumors and inflammatory disease |
05/28/2002 | US6394945 Radioactively coated devices |
05/28/2002 | CA2079493C Imaging agent for diagnosis |
05/23/2002 | WO2002040507A2 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers |
05/23/2002 | WO2002040092A2 Directional energy emitting implant |
05/23/2002 | WO2002040060A2 Conjugates of an antioxidants with metal chelating ligands |
05/23/2002 | WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
05/23/2002 | WO2001082971A3 Cyclodextrin containing glycopeptide antibiotic compositions |
05/23/2002 | US20020061909 Vitronectin receptor antagonist pharmaceuticals |
05/23/2002 | US20020061279 18F-labeled choline analogs |
05/23/2002 | CA2421182A1 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications |
05/22/2002 | EP1206493A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
05/22/2002 | EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives |
05/22/2002 | EP1206288A2 Targeted fiberless radiative effectors |
05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
05/22/2002 | EP1206252A1 Amplification of folate-mediated targeting to tumor cells using polymers |
05/22/2002 | EP0745085B1 Texaphyrin metal complexes having improved functionalization |
05/21/2002 | USRE37710 Radiometal-binding analogues of luteinizing hormone releasing hormone |
05/21/2002 | US6392246 Integrated radiation shield |
05/21/2002 | US6391630 Nucleotide sequences for use in the diagnosis, prevention and treatment of cancer |
05/21/2002 | US6391280 J chain polypeptide targeting molecule linked to an imaging agent |
05/21/2002 | US6391279 Radioactive seeds for brachytherapy and a process for making the same |
05/21/2002 | CA2148595C Molecule labelling using 2-hydrazinopyridine derivatives |
05/16/2002 | WO2002022000A3 Targeted alpha particle therapy using actinium-225 conjugates |
05/16/2002 | WO2001058434A3 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
05/16/2002 | US20020058853 Method of administering a therapeutically active substance |
05/16/2002 | US20020058850 Radioactive medical devices and methods of making radioactive medical devices |
05/16/2002 | US20020058615 Endothelial specific targeting |
05/16/2002 | US20020058057 Brachytherapy seed |
05/16/2002 | US20020058033 Human anti-epidermal growth factor receptor single-chain antibodies |
05/16/2002 | US20020058007 Targeted alpha particle therapy using actinium-225 conjugates |
05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
05/15/2002 | EP1204650A1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
05/15/2002 | EP1204426A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
05/14/2002 | US6387350 Utilizing a labeled single chain antibody fragment or subfragment with a molecular weight of 85,000 daltons or less that specifically binds to an antigen produced by or associated with tumors or lesions |
05/14/2002 | CA2032499C Polypeptide derivatives |
05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
05/10/2002 | WO2002036581A1 Radiopharmaceuticals for diagnosing alzheimer's disease |
05/10/2002 | WO2002036174A1 Radio-labelled ferrite particles and methods for the manufacture and use thereof |
05/10/2002 | WO2002036173A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
05/10/2002 | WO2001077145A3 Integrin binding peptide derivatives |
05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
05/10/2002 | WO2001019799A3 Nitroimidazole derivative and diagnostic imaging agent containing the same |
05/10/2002 | CA2427911A1 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
05/10/2002 | CA2427130A1 Radio-labelled ferrite particles and methods for the manufacture and use thereof |
05/10/2002 | CA2424598A1 Radiopharmaceuticals for diagnosing alzheimer's disease |